Latest Insider Transactions at Immunome Inc. (IMNM)
This section provides a real-time view of insider transactions for Immunome Inc. (IMNM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Immunome Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Immunome Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 06
2020
|
John L Lamattina Director |
BUY
Conversion of derivative security
|
Direct |
46,388
+50.0%
|
-
|
|
Oct 06
2020
|
Michael Lefenfeld Director |
BUY
Conversion of derivative security
|
Direct |
22,222
+50.0%
|
-
|
|
Oct 06
2020
|
I Wistar Morris Iii > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
38,464
+50.0%
|
-
|
|
Oct 06
2020
|
I Wistar Morris Iii > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
882,475
+50.0%
|
-
|
|
Oct 06
2020
|
Michael Rapp Director |
BUY
Open market or private purchase
|
Direct |
83,332
+11.54%
|
$999,984
$12.0 P/Share
|
|
Oct 06
2020
|
Michael Rapp Director |
BUY
Conversion of derivative security
|
Direct |
555,554
+50.0%
|
-
|
|
Oct 06
2020
|
Michael Widlitz Director |
BUY
Conversion of derivative security
|
Direct |
51,315
+50.0%
|
-
|